|
|
3. Marijuana-Based Medicines—Marinol® and Cesamet® are synthetic (man-made) THC, approved by FDA in the 1980s to treat chemotherapy-related nausea and AIDs wasting in patients who do not respond to standard medications. There is no need to legalize marijuana-based medicines. They are legal for patients to possess and use while taking part in research studies and clinical trials and with a prescription once the drugs are approved by FDA.
|
|
|
4. Marijuana Based Medicines Seeking FDA Approval—Sativex®, combined THC and CBD, and Epidiolex®, CBD, are in clinical trials in the US to treat advanced cancer pain and intractable epileptic seizures, respectively. The British firm GW Pharmaceuticals grows marijuana without the use of pesticides and purifies the THC and CBD extracted from the marijuana. Insys Therapeutics plans to begin clinical trials in 2015 of its marijuana-based medicine, synthetic CBD, to treat epileptic seizures.
|
|
|
With this edition of E-Highlights, National Families in Action and partners, Project SAM and the Treatment Research Institute, welcome a number of new readers. We hope you enjoy this weekly e-newsletter to keep up-to-date with all aspects of the marijuana story.
National Families in Action (NFIA) is a nonprofit drug policy, education, and prevention organization founded in Atlanta in 1977. Learn more about marijuana at our new website The Marijuana Report.Org and by subscribing to E-Highlights. Learn more about the difference between medical marijuana and marijuana-based medicines at The Marijuana Report.Org: Reports.
|
|
|
|
|
|